allanore yannick

Rheumatologist at Cochin Hospital (head of rheumatology department) and researcher at Cochin Institute with special interest in systemic sclerosis

[allanore yannick @allanore]

Skin score supervised by Pr Khanna at WSC

[allanore yannick @allanore]

I’m honored to be speaking at the 9th World Congress on Systemic Sclerosis in Athens, from March 5–7, 2026: I’ll be presenting on Session 15 Therapy. Congress programme available online. Join me to explore the latest science and clinical advances in systemic sclerosis.

[World Scleroderma Foundation @Worldsclerofnd]

📢 Save the date!#SScWorldCongress 2026 is heading to Athens 🇬🇷
🗓 Abstracts due: Sept 1, 2025
🎟 Early Bird Reg: Jan 8, 2026
Be part of the leading global event in systemic sclerosis. Don’t miss it!
#SSc2026 #Scleroderma #Rheumatology #MedTwitter

[World Scleroderma Foundation @Worldsclerofnd]

📢 Meet us at #EULAR2025 in Barcelona! 3 day to go
📅 June 11–15 | 📍 Booth O19, Hall 8.1
🎤 Sessions & interviews by EUSTAR YIG
🤝 WSF Membership Area
💡 Apply for our Major & Young Investigator Grants!
🔗 Info:https://t.co/0vzaOQoaEa
#Scleroderma #WSF #MedicalResearch #Grants

[EUSTAR @EUSTAR_org]

✨Congratulations to our YIG members that their #EUSTAR abstracts have been accepted for #EULAR2025
🎯@CorradoCampoch1:Evidence-based detection of progression of systemic sclerosis-interstitial lung disease patients: the EUSTAR-PPF study (CP number 148).
📌B2,11 June4:40 - 4.50pm

[allanore yannick @allanore]

Systemic Sclerosis: A Multisystem Disease; Time to Think Beyond Scleroderma https://t.co/4Qdc5hXmbr

[EUSTAR @EUSTAR_org]

🔥#EUSTAR course, Bordeaux 2025 🔥

✨3 briliant days full of #SSc brainstorming are behind us✨

✨We are proud of all the participants! Thank you for the wonderful discussions and for being very motivated and passionate about #SSC!✨

🎯Stay tuned with us!

[World Scleroderma Foundation @Worldsclerofnd]

⏳2 days to go! The EUSTAR Course 2025 kicks off in Bordeaux on Feb 6! 🔬✨oin top experts to explore the latest in SSc research, early diagnosis, ILD, PAH, GI challenges & more.📲 Stay tuned for live updates & expert insights! @EUSTAR_org #SSc #MedicalEducation

[Healio Rheumatology @HealioRheum]

👨‍⚕️@eular_org has new recommendations for the treatment of #SystemicSclerosis, with new approaches to PAH, skin fibrosis & other 🔑 key manifestations

Here's a rundown from authors @allanore & @delgaldoFrances 👇

https://t.co/pTHrOMczfB

[Reumatologia Sant Pau-Dos de Maig @reuma_santpau]

Arranquem amb el 2n dia del VII Curs de MAS de la @SCReuma!

Comencem amb la conferència magistral del prof. Yanick Allanore @allanore de @HopitalCochin.

Systemic Sclerosis: update in treatment recommendations.

An honour to have you! Thank you for the outstanding lecture.

[allanore yannick @allanore]

Results from the international collaborative systematic literature review informing the 2023 EULAR recommendations for the treatment of systemic sclerosis https://t.co/n8yThGMNOX

[allanore yannick @allanore]

Lay summary about the EULAR update on systemic sclerosis treatment :

https://t.co/nZbCizj6BZ

[Annals of the Rheumatic Diseases @eular_ARD]

Check out the latest update of @eular_org recommendations for #systemic #sclerosis treatment

▶️ 22 recommendations covering 8 clinical domains
▶️ new recommendations on treatments for skin fibrosis and lung disease
▶️ first- & second-line interventions
🔗 https://t.co/QopiRZnX7Z

[allanore yannick @allanore]

After a long but stimulating journey, the update in systemic sclerosis recommendations is available, enjoy the reading and a big thank to the outstanding task force https://t.co/4A7MB27mjl

[allanore yannick @allanore]

the Fully updated third edition has reached > 10k accesses
It Provides a concise synthesis of pathogenesis and modern approaches to management of systemic sclerosis
It Presents an integrated multidisciplinary approach to comprehensive patient care

[allanore yannick @allanore]

Glad to attend the Brazilian Society in Belo Horizonte. Large audience today for discussions on the Update of the recommandations on systemic sclerosis. Insights are the availability of synthetic and biologic DMARDS, 3 drugs labelled in some countries!